Clinical Trial Update: Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating autologous immune killer cells in patients with late-stage non-small cell lung cancer and hepatocellular carcinoma has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Autologous Immune Killer Cells

Snippet

Sponsor: Ivy Life Sciences, Co., Ltd | Conditions: NSCLC Stage IIIB, NSCLC Stage IV | Phase 1 | Status: COMPLETED